跳至主要内容
临床试验/NCT07172542
NCT07172542尚未招募不适用

High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

Centre Hospitalier de Gonesse1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Hematoma Expansion within 48 Hours: Increase of more than 6 mL or over 30% between the initial CT and the follow-up CT (PREDICT study criterion) and/or Occurrence of Death Within the First Month

研究概览

简要总结

This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan.
  • Follow-up CT scan performed within 24 to 48 hours.
  • Non-inclusion Criteria :
  • Absence of initial contrast-enhanced CT or follow-up CT.
  • Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH).

排除标准

  • Patient deceased before the initial contrast-enhanced CT.
  • Major missing clinical data.

结局指标

主要结局

Hematoma Expansion within 48 Hours: Increase of more than 6 mL or over 30% between the initial CT and the follow-up CT (PREDICT study criterion) and/or Occurrence of Death Within the First Month

时间窗: 48 hours

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier de Gonesse
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

High Risk of Death or Disability in Brain... | 临床试验